Mucosal immunisation and adjuvants: a brief overview of recent advances and challenges (Q35134733)

6 August 2017

1 reference

title

Mucosal immunisation and adjuvants: a brief overview of recent advances and challenges (English)

1 reference

6 August 2017

1

Jan Holmgren

1 reference

6 August 2017

2

Cecil Czerkinsky

1 reference

6 August 2017

Kristina Eriksson

3

1 reference

PubMed ID

12763689

6 August 2017

Ali Mharandi

series ordinal

4

1 reference

PubMed ID

12763689

6 August 2017

language of work or name

English

0 references

publication date

1 June 2003

1 reference

6 August 2017

1 reference

6 August 2017

21 Suppl 2

1 reference

6 August 2017

S89-95

1 reference

Mucosal vaccination overcomes the barrier to recombinant vaccinia immunization caused by preexisting poxvirus immunity

6 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900206-8

7 January 2021

Induction and expression of intestinal humoral immunity in HIV-infected individuals: prospects for vaccination against secondary enteric infections

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900206-8

7 January 2021

Oral tolerance: mechanisms and therapeutic applications.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900206-8

7 January 2021

Intussusception among infants given an oral rotavirus vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900206-8

7 January 2021

Effects of insulin in relatives of patients with type 1 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900206-8

7 January 2021

Control of rheumatoid arthritis by oral tolerance

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900206-8

7 January 2021

Cholera toxin and cholera B subunit as oral-mucosal adjuvant and antigen vector systems

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900206-8

7 January 2021

The mechanism of cholera toxin adjuvanticity

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900206-8

7 January 2021

Effects of the adjuvant cholera toxin on dendritic cells: stimulatory and inhibitory signals that result in the amplification of immune responses

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900206-8

7 January 2021

Cholera toxin and its B subunit promote dendritic cell vaccination with different influences on Th1 and Th2 development

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900206-8

7 January 2021

Nasal or intramuscular immunization of mice with influenza subunit antigen and the B subunit of Escherichia coli heat-labile toxin induces IgA- or IgG-mediated protective mucosal immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900206-8

7 January 2021

Cholera toxin B subunit as a carrier molecule promotes antigen presentation and increases CD40 and CD86 expression on antigen-presenting cells

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900206-8

7 January 2021

Mucosal vaccines: non toxic derivatives of LT and CT as mucosal adjuvants.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900206-8

7 January 2021

CTA1-DD-immune stimulating complexes: a novel, rationally designed combined mucosal vaccine adjuvant effective with nanogram doses of antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900206-8

7 January 2021

Detoxification of cholera toxin without removal of its immunoadjuvanticity by the addition of (STa-related) peptides to the catalytic subunit. A potential new strategy to generate immunostimulants for vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900206-8

7 January 2021

The Toll receptor family and microbial recognition

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900206-8

7 January 2021

CpG motifs in bacterial DNA and their immune effects

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900206-8

7 January 2021

CpG DNA is an effective oral adjuvant to protein antigens in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900206-8

7 January 2021

Intranasal immunization with CpG oligodeoxynucleotides as an adjuvant dramatically increases IgA and protection against herpes simplex virus-2 in the genital tract

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900206-8

7 January 2021

A protective role of locally administered immunostimulatory CpG oligodeoxynucleotide in a mouse model of genital herpes infection

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900206-8

7 January 2021

Cytokine requirements for induction of systemic and mucosal CTL after nasal immunization

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900206-8

7 January 2021

Immunopotentiation of DNA vaccine against herpes simplex virus via co-delivery of plasmid DNA expressing CCR7 ligands

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900206-8

7 January 2021

RANTES potentiates antigen-specific mucosal immune responses

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900206-8

7 January 2021

Chimeric recombinant hepatitis E virus-like particles as an oral vaccine vehicle presenting foreign epitopes

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900206-8

7 January 2021

Recombinant Norwalk virus-like particles administered intranasally to mice induce systemic and mucosal (fecal and vaginal) immune responses

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900206-8

7 January 2021

Papillomavirus pseudovirus: a novel vaccine to induce mucosal and systemic cytotoxic T-lymphocyte responses

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900206-8

7 January 2021

Infection of human dendritic cells by a sindbis virus replicon vector is determined by a single amino acid substitution in the E2 glycoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900206-8

7 January 2021

Human immunodeficiency virus type 1 Gag-specific vaginal immunity and protection after local immunizations with sindbis virus-based replicon particles

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900206-8

7 January 2021

A cholera toxoid-insulin conjugate as an oral vaccine against spontaneous autoimmune diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900206-8

7 January 2021

Treatment of experimental autoimmune arthritis by nasal administration of a type II collagen-cholera toxoid conjugate vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900206-8

7 January 2021

Oral administration of cholera toxin B subunit conjugated to myelin basic protein protects against experimental autoimmune encephalomyelitis by inducing transforming growth factor-beta-secreting cells and suppressing chemokine expression

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900206-8

7 January 2021

Prolonged oral treatment with low doses of allergen conjugated to cholera toxin B subunit suppresses immunoglobulin E antibody responses in sensitized mice

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900206-8

7 January 2021

Oral administration of recombinant cholera toxin subunit B inhibits IL-12-mediated murine experimental (trinitrobenzene sulfonic acid) colitis

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900206-8

7 January 2021

Nasal Administration of Schistosoma mansoni Egg Antigen-Cholera B Subunit Conjugate Suppresses Hepatic Granuloma Formation and Reduces Mortality in S. mansoni-Infected Mice

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900206-8

7 January 2021

A mucosally administered recombinant fusion protein vaccine against schistosomiasis protecting against immunopathology and infection

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900206-8

7 January 2021

Selective tolerization of Th1-like cells after nasal administration of a cholera toxoid-LACK conjugate

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900206-8

7 January 2021

Prevention of mucosally induced uveitis with a HSP60-derived peptide linked to cholera toxin B subunit

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900206-8

7 January 2021

10.1016/S0264-410X(03)00206-8

Identifiers

DOI

1 reference

6 August 2017

1 reference

PubMed ID

12763689